Corporate News Report – Baird Medical Investment Hol (BDMD) and Related Securities
Baird Medical Investment Hol (BDMD)
| Item | Value |
|---|---|
| Price (26 Nov 2026) | USD 0.45 |
| Price change (24 h) | –1.55 % |
| Market Capitalisation | USD 18.8 million |
| Shares Outstanding | 41.8 million |
| Volume (last 24 h) | USD 26.6 thousand |
| 52‑week High | USD 3.70 (02 Mar 2026) |
| 52‑week Low | USD 0.40 (19 Oct 2026) |
| Simple Moving Average (200 days) | USD 1.36 |
| Month‑end Decline | –42.82 % |
Baird Medical Investment Hol closed the trading session at USD 0.45, reflecting a decline of 1.55 % compared to the previous day. The stock is currently being traded on major exchanges at the stated price. With 41.8 million shares outstanding, the company’s market capitalisation stands at USD 18.8 million. In the most recent 24‑hour period, approximately USD 26.6 k of Baird Medical Investment Hol shares were exchanged.
Over the past month, the stock has fallen 42.82 %. The simple moving average over the past 200 trading days is USD 1.36. The highest price achieved in the preceding 52 weeks was USD 3.70 on 2 March 2026, while the lowest price was USD 0.40 on 19 October 2026.
Related Stock Performance (Last 24 Hours)
| Ticker | Exchange | Price Change (24 h) | Current Price | Market Capitalisation |
|---|---|---|---|---|
| 8073.HK (China Shuifa Singyes New Mat) | HKSE | 0 % | HKD 0.31 | HKD 176.8 million |
| 0042.HK (Northeast Electric Develop‑h) | HKSE | +9.29 % | HKD 0.20 | HKD 174.7 million |
| 1575.HK (Regal) | HKSE | –2.13 % | HKD 0.04 | HKD 174.1 million |
| UPC (Universe Pharmaceutical) | OTC | –0.91 % | USD 4.34 | USD 21.8 million |
| 1966.HK (China Sce) | HKSE | –2.38 % | HKD 0.04 | HKD 173.1 million |
Regulatory Filings – Regal (1575.HK)
Regal Partners Holdings Pty Limited filed a notice on 22 October 2026 concerning changes in its substantial holdings, following an earlier notice on 20 July 2026. The filing detailed:
- Current voting interests held by Regal Partners Funds Management Pty Limited and its associates, comprising ordinary shares.
- Quantities of shares acquired and sold during early and mid‑October.
- Registered holders and nominee arrangements, including UBS, HSBC, Morgan Stanley, JPMorgan, and Merrill Lynch nominees.
- Confirmation that the substantial holder’s voting power remained significant.
- Total shares on issue as of early September: 689,991,565.
No additional corporate actions or financial performance updates were reported in the filing.
